From Morningstar: 2024-06-06 06:27:00

The share price of the International Biotechnology Trust dropped 8.38% in one year, attributed to macro factors and volatility in biotech. Gilead Sciences, top holding, has reinvented itself multiple times, benefiting patients with HIV and Hepatitis C. Amgen’s anti-obesity injection, MariTide, shows promising data for weight loss. Record number of US healthcare companies filed for bankruptcy in 2023, signaling a cleanup of low-quality companies. US healthcare sector thrived under Trump presidency, and Biden administration achieved legislation allowing Medicare to negotiate drug prices. UK investors in the trust may benefit from the private sector’s influence on the NHS by investing in innovative branded drugs that keep patients out of hospitals.



Read more at Morningstar: Healthcare Companies Are Going Bust. Should I be…